This is a StreetInsider.com Premium Only Page

Puma Biotech (PBYI) –

Apr 18, 2024 04:15 PM Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

Apr 3, 2024 05:30 PM Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Mar 29, 2024 10:41 AM Form SC 13G PUMA BIOTECHNOLOGY, INC. Filed by: Frazier Life Sciences Public Fund, L.P.

Mar 20, 2024 08:30 AM Puma Biotech (PBYI) Announces FDA Allowance to Proceed Under IND for Alisertib

Mar 20, 2024 08:30 AM Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer

Mar 19, 2024 09:02 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Mar 15 Filed by: AUERBACH ALAN H

Mar 19, 2024 04:12 PM Puma Biotech (PBYI) Provides Update on AstraZeneca (AZN) Litigation

Mar 19, 2024 04:06 PM Form 8-K PUMA BIOTECHNOLOGY, INC. For: Mar 18

Feb 29, 2024 04:47 PM Form 10-K PUMA BIOTECHNOLOGY, INC. For: Dec 31

Feb 29, 2024 04:18 PM Form 8-K PUMA BIOTECHNOLOGY, INC. For: Feb 29

Feb 29, 2024 04:14 PM Puma Biotech (PBYI) Tops Q4 EPS by 1c, offers outlook

Feb 29, 2024 04:05 PM Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27, 2024 06:30 PM Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Feb 22, 2024 04:10 PM Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference

Feb 15, 2024 04:10 PM Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results

Feb 14, 2024 06:04 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Feb 12 Filed by: Wong Alvin F

Feb 14, 2024 06:02 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Feb 12 Filed by: NOUGUES MAXIMO F

Feb 14, 2024 06:01 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Feb 12 Filed by: Ludwig Jeffrey Jerome

Feb 14, 2024 05:59 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Feb 12 Filed by: AUERBACH ALAN H

Feb 14, 2024 05:54 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Feb 12 Filed by: HUNT DOUGLAS M

Feb 14, 2024 08:19 AM Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: Camber Capital Management LP

Feb 13, 2024 06:00 PM Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: VANGUARD GROUP INC

Feb 13, 2024 08:30 AM Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer

Feb 6, 2024 03:55 PM Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: ACORN BIOVENTURES, L.P.

Jan 30, 2024 04:09 PM Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: MILLENNIUM MANAGEMENT LLC

Jan 18, 2024 09:01 AM Form 8-K PUMA BIOTECHNOLOGY, INC. For: Jan 18

Jan 11, 2024 04:07 PM Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference

Jan 10, 2024 04:42 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Dec 04 Filed by: Wong Alvin F

Jan 10, 2024 04:39 PM Form 144/A PUMA BIOTECHNOLOGY, INC. Filed by: Wong Alvin F

Jan 5, 2024 07:04 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Jan 03 Filed by: Wong Alvin F

Jan 5, 2024 07:01 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Jan 03 Filed by: Ludwig Jeffrey Jerome

Jan 5, 2024 06:56 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Jan 03 Filed by: AUERBACH ALAN H

Jan 5, 2024 06:50 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Jan 03 Filed by: NOUGUES MAXIMO F

Jan 5, 2024 06:43 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Jan 03 Filed by: HUNT DOUGLAS M

Jan 3, 2024 09:41 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: NOUGUES MAXIMO F

Jan 3, 2024 09:40 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: Ludwig Jeffrey Jerome

Jan 3, 2024 09:36 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: Wong Alvin F

Jan 3, 2024 09:34 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: HUNT DOUGLAS M

Jan 3, 2024 09:31 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: AUERBACH ALAN H

Dec 11, 2023 08:37 AM Puma Biotech (PBYI) Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer

Dec 11, 2023 08:30 AM Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer

Nov 9, 2023 04:21 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Nov 07 Filed by: MILLER MICHAEL PATRICK

Nov 7, 2023 08:58 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: MILLER MICHAEL PATRICK

Nov 6, 2023 05:15 PM Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Nov 3, 2023 08:08 AM Puma Biotechnology (PBYI) PT Lowered to $4 at TD Cowen

Nov 2, 2023 04:55 PM Puma Biotech (PBYI) Tops Q3 EPS by 10c; Offers FY23 Revenue Guidance

Nov 2, 2023 04:42 PM Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Sep 30

Nov 2, 2023 04:20 PM Form 8-K PUMA BIOTECHNOLOGY, INC. For: Nov 02

Nov 2, 2023 04:05 PM Puma Biotechnology Reports Third Quarter 2023 Financial Results

Oct 19, 2023 04:14 PM Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results